References
- DeBold A. J., Borenstein H. B., Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to the intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89–94
- Currie M. G., Geller D. M., Cole B. R., Boylen J. G., Yu Sheng W., Holmberg S. W., Needleman P. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 1983; 221: 71–73
- Kleinert H. D., Maack T., Atlas S. A., Sealey J. E., Laragh J. H. Atrial natriuretic factor inhibits angiotension-, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6: 1143–1147
- Winquist R. J., Faison E. P., Waldman S. A., Schwartz K., Murad F., Rapoport R. M. Atrial natriuretic factor elicits an endothelium-independent relaxation and activitates particulate guanylate cyclase in vascularsmooth muscle. Proc natn Acad Sci, U.S.A 1984; 81: 7661–7664
- Vesely D. L., Norris J. S., Walters J. M., Jespersen R. R., Baeyens D. A. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem Biophys Res Commun 1987; 148: 1540–1548
- Vesely D.L., Bayliss J. M., Sallman A. L. Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun 1987; 143: 186–193
- Winters C.J., Sallman A. L., Meadows J., Rico D. M., Vesely D.L. Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231–236
- Tang J., Song D. L., Suen M. Z., Xie C. W., Chang D., Chang J. K. Alpha-human atrial natriuretic polypeptide (alpha-h ANP) in normal volunteers and patients with heart failure or hypertension. Peptides 1986; 7: 33–37
- Peeters T. L., Depraetere Y., Van trappen G. R. Simple extraction method and radioimmunoassay for somatostatin in human plasma. Clin Chem 1981; 27: 888–891
- Donckier J., Anderson J.V., Yeo T., Bloom S. R. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. N Engl J Med 1986; 315: 710–711
- Richards A. M., Tonolo G., Fraser R., Morton J. J., Leckie B. J., Ball S. G., Robertson J. I. S. Diurnal change in plasma atrial natriuretic peptide concentrations. Clin Sci 1987; 73: 489–495
- Sakurai H., Naruse M., Naruse K., Obana K., Higashida T., Kurimoto F., Demura H., Inagami T., Schizume K. Postural suppression of plasma atrial natriuretic polypeptide concentrations in man. Clin Endocrinol 1987; 26: 173–178
- Opgenorth T. J., Burnett J. C., Jr., Granger J. P., Scriven T. A. Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney. Am J Physiol 1986; 250: F798–F801
- Grim C., Winnacker J., Peters T., Gilbert G. Low renin, “normal” aldosterone and hypertension: circadian rhythm of renin, aldosterone, Cortisol and growth hormone. J Clin Endocrinol Metab 1974; 39: 247–256
- Gordon R. D., Wolfe L. K., Island D. P., Liddle G. W. A diurnal rhythm in plasma renin activity in man. J Clin Invest 1966; 45: 1587–1592
- Modlinger R. S., Sharif-Zadeh K., Ertel N. H., Gutkin M. The circadian rhythm of renin. J Clin Endocrinol Metab 1976; 43: 1276–1282